SCHEMBL28119962

SCHEMBL28119962

CC[C@@H]1CCC(C=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28051614 1.00
SCHEMBL8030877 1.00
SCHEMBL8354546 1.00
SCHEMBL27535585 0.87 ADH1A (0.34)
SCHEMBL27380311 0.87 ADH1A (0.34)
SCHEMBL9538517 0.79 S1PR2 (0.44)
SCHEMBL27619614 0.77
SCHEMBL27333654 0.77
SCHEMBL27758839 0.77
SCHEMBL11917908 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109983007-A Amide derivatives inhibitor and its preparation method and application 江苏豪森药业集团有限公司 2019-07-05 CN disclosed
CN-109851610-A Azabicyclo compound as muscarine M1 and/or M4 receptor stimulating agent 赫普泰雅治疗有限公司 2019-06-07 CN disclosed
CN-106458986-B Bicyclic aza compounds as muscarinic M1 and/or M4 receptor agonists 赫普泰雅治疗有限公司 2019-01-04 CN disclosed
CN-107949384-A Muscarinic agonists 赫普泰雅治疗有限公司 2018-04-20 CN disclosed
CN-106458986-A Bicyclic aza compounds as muscarinic M1 and/or M4 receptor agonists 赫普泰雅治疗有限公司 2017-02-22 CN disclosed